Skip to site menu Skip to page content

Daily Newsletter

27 November 2025

Daily Newsletter

27 November 2025

FluidAI acquires Emmetros to expand patient engagement platform

By integrating Stream Inara into the RISE Programme, hospitals can enable patients to recover at home.

Salong Debbarma November 27 2025

Canada-based FluidAI Medical has acquired Emmetros, a developer of the SparxConnect platform, to expand its AI-powered patient engagement platform, Stream Inara.

Stream Inara also serves as a patient education platform within the product portfolio of FluidAI that extends care beyond the hospital.

The deal marks FluidAI’s second acquisition after Medsix.

FluidAI’s Stream Inara platform operates within its Recovery Intelligence and Surgical Excellence (RISE) quality improvement programme.

RISE covers the entire surgical journey and includes the FDA-cleared Origin monitoring device; Stream Inara for post-discharge support; and Stream Care, an AI-assisted surgical expert suite.

The integration of Emmetros’ technology is expected to improve patient engagement and education at home.

Stream Inara functions as a digital management tool for patients both before surgery and after they return home. It offers 24/7 support, monitors discharged patients, delivers personalised education, collects patient-reported outcomes, and maintains continuous engagement.

This approach aims to improve adherence to care plans and support safer and earlier discharge for surgical patients.

By integrating Stream Inara into the RISE Programme, hospitals can enable patients to recover at home while increasing throughput and optimising bed utilisation.

Clinicians benefit from maintaining continuous connection with patients throughout the recovery process, supporting better experiences and outcomes.

Emmetros CEO and co-founder Mary Pat Hinton said: “I could not be more pleased about this acquisition by FluidAI, which represents the best possible next chapter for our technology and our mission.

“Their team shares our deep commitment to improving surgical patient outcomes and care experiences through innovation, and their expertise in real-time continuous monitoring really is the perfect complement to our highly customisable and extensible patient engagement and collaboration platform.”

In October 2023, FluidAI Medical secured $15m in a Series A investment round to support its AI-powered postoperative patient monitoring system.

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close